🎉 Special Offer: Get 10% OFF on your video consultation with our verified doctors!
Dr. Ritesh Gupta - Internal medicine in Delhi

Dr. Ritesh Gupta

MBBS, MD - General Medicine

Internal medicineInternal medicine
  • Delhi, Delhi
  • 10 Awards

Is this your profile? Need to edit info? Click Here

Clinic Locations

Fortis C-DOC Hospital

B-16, Chirag Enclave, Delhi, Delhi, India

Services

  • Type 1 Diabetes Treatment (Treatment for insulin dependent diabetes)
  • Thyroid Disorder Treatment
  • Diabetic Foot Disease (diabetes foot disorder treatment)
  • Insulin Therapy (insulin treatment for diabetes)
  • Male Sexual Dysfunction and Hormonal Disorders (sexual health and hormone problems in men)
  • Peritoneal Dialysis (dialysis through abdomen lining)
  • Arthritis Management (treatment for joint inflammation disease)
  • Irritable Bowel Syndrome Treatment (treatment for IBS digestive disorder)
  • Congenital Disorders Evaluation / Treatment
  • Chickenpox Treatment (treatment for chickenpox infection)
  • Bronchial Asthma Treatment (treatment for asthma breathing disease)
  • Vaccination and Immunization (disease protection vaccines)
  • Infectious Disease Treatment (Treatment for infectious illnesses)
  • Immunotherapy (immune system disease treatment)
  • Gestational Diabetes Management (pregnancy diabetes care)
  • Joint and Muscle Disorders (Muscle joint problem treatment)
  • Chronic Kidney Disease (Long-term kidney disease care)
  • Hypertension Treatment (high blood pressure treatment)
  • General Health Checkup (Routine health screening)
  • Pediatric Diabetes (child diabetes treatment)
  • Diabetic Kidney Disease (diabetes kidney complication care)
  • Abdominal Pain Treatment (treatment for stomach pain)
  • Chronic Pain Management (long-term pain treatment)
  • Bioidentical Hormone Therapy (natural hormone replacement treatment)
  • Diabetes Management (Treatment to control diabetes)
  • COPD Treatment (treatment for chronic lung disease)
  • Cough Treatment (Medical treatment for cough symptoms)
  • Tuberculosis Treatment (treatment for TB infection)
  • Type 2 Diabetes Treatment (Treatment for adult onset diabetes)
  • Hypertriglyceridemia (high triglyceride level condition)
  • Diabetic Ulcer Treatment (diabetes foot wound treatment)
  • Dyslipidemia (Abnormal blood cholesterol levels)
  • Electrophysiology Study (Heart rhythm electrical test)
  • Emaciation (Severe weight loss condition)
  • Preoperative Care (before surgery preparation)
  • Fibromyalgia Treatment (Chronic muscle pain treatment)
  • Foot Infection (infection in foot tissues)
  • Post-Obesity Management (Weight loss maintenance care)
  • Hormonal Therapy (hormone-based treatment)
  • Malaria Treatment (Malaria infection treatment)
  • Peptic Ulcer Treatment (Stomach ulcer treatment)
  • Jaundice Treatment (Yellow skin liver treatment)
  • Plantar Fasciitis (heel pain foot condition treatment)
  • Gastroenteritis Treatment (Stomach infection treatment)
  • Migraine Treatment (treatment for severe headache)
  • Typhoid Fever Treatment (treatment for typhoid infection)
  • Gout Treatment (Joint uric acid treatment)
  • Anemia Treatment (Low hemoglobin treatment)
  • Appendicitis Treatment (Appendix inflammation treatment)
  • ENT Checkup (ear nose throat check)
  • Rheumatic Heart Disease Treatment (treatment for rheumatic heart condition)

Education

  • All India Institute of Medical Sciences, New Delhi - Jan-1994 Graduated
    none, none, none
    MBBS
  • All India Institute of Medical Sciences, New Delhi - Jan-1998 Graduated
    none, none, none
    MD - General Medicine

Work & Experience

  • Fortis C-DOC Centre of Excellence for Diabetes, Metabolic Diseases and Endocrinology
    Thanesar, Haryana, India
    Additional Director at Fortis C-DOC
  • Fortis C-DOC Centre of Excellence for Diabetes, Metabolic Diseases and Endocrinology
    Thanesar, Haryana, India
    Head Clinical Operations and Senior Consultant
  • Fortis Flt Lt Rajan Dhall Hospital, Vasant Kunj
    Thanesar, Haryana, India
    Consultant in the Department of Diabetes and Metabolic Disease
  • an initiative of Apollo Health and Lifestyle Limited
    Thanesar, Haryana, India
    Consultant in Internal Medicine at Apollo Clinic
  • Escorts Heart Institute and Research Centre
    Thanesar, Haryana, India
    Senior Resident in the Department of Cardiology and as Internist
  • All India Institute of Medical Sciences
    Thanesar, Haryana, India
    Senior Resident (Registrar) in the Department of Medicine

Awards

  • Handa R, Gupta R, Wig N, Agarwal P, Wali JP. Microfilariae of Wuchereria bancrofti in Ascitic Fluid. Indian J Med Sci

  • Gupta R, Prasad HK, Nagarkar KM, Dey AB. Preliminary study on circulating serum levels of tumor necrosis factor-Alpha in patients of tuberculosis. Indian J Clin Biochem

  • Misra A, Chowbey P, Makkar BM, Vikram NK, Wasir JS, Chadha D, Joshi SR, Sadikot S, Gupta R, Gulati S, Munjal YP; Consensus Group. Consensus Statement for Diagnosis of Obesity, Abdominal Obesity and the Metabolic Syndrome for Asian India

  • Gupta R, Misra A. Screening For And Prevention Of Diabetes In India: Need For Simple And Innovative Strategies. Diabetes Technol Ther

  • Subramanian A, Nigam P, Misra A, Pandey Rn, Mathur M, Gupta R, Madhusudan S. Severe Vitamin D Deficiency In Patients With Type 2 Diabetes In North India

  • Co-investigator In The Trial Titled Phase 2, 12 Week Randomized, Double Blind, Parallel Group Placebo-controlled Study To Evaluate Safety, Tolerability, And Efficacy Of Grc 8200, A New Oral Dpp-iv Inhibitor, In Patients With Type 2 Diabe

  • Co-investigator In The Trial Titled Multicenter, Randomized, Double Blind, Placebo-controlled Clinical Trial To Evaluate The Effect Of 52 Weeks Treatment With Vildagliptin On Left Ventricular Function In Patients With Type 2 Diabetes

  • Co-investigator In The Trial Titled Randomized, Double-blind, Placebo- And Sitagliptin-controlled, Multi-center Study To Evaluate Safety And Efficacy Of Dutogliptin In Type 2 Diabetes Mellitus Subjects With Moderate And Severe Renal Impai

  • Co-investigator In The Trial Titled 12- Week Multicenter, Randomized, Double Blind, Placebo-controlled Parallel Group Adaptive Design Study To Evaluate The Efficacy On Blood Glucose Control And Safety Of Five Doses Of Lcq

  • Co-investigator In The Trial Titled Multicentre, Randomized, Double-blind, Placebo-controlled Phase Iv Trial To Evaluate The Effect Of Saxagliptin On The Incidence Of Cardiovascular Death, Myocardial Infarction Or Ischemic Stroke In Patie

questions and answer empty

Get Your Health Questions Answered Online By the Doctor.

Ask Free Question
Is this your profile? Need to edit info? Click Here

Similar Doctors

Choose Consultation Mode

{{AppConsultName}}

{{appConsultfee}}

{{appClinicName}}

{{appClinicLocality}}

No slots available for {{appslot.Sdate}} {{appslot.month}} to {{appslot.Edate}} {{appslot.endmonth}}

No slots available for {{appslot.Sdate}} {{appslot.month}}

Select Another Date